• Strategic Activation of the Smoothened Receptor: SAG’s Trans

  2026-07-09

  This article examines the mechanistic and translational relevance of the Smoothened Agonist (SAG) in modulating Hedgehog pathway signaling, myelin regeneration, and immune dynamics. Drawing on recent evidence, including sex-dependent immune effects and mitochondrial rescue, it provides strategic guidance for researchers leveraging SAG in disease modeling, pathway assays, and regenerative workflows. The piece situates APExBIO’s SAG offering within a rigorously evidence-based landscape, bridging protocol optimization and emerging challenges in translational neuroscience.

• Decoding Firefly Luciferase mRNA: Next-Gen 5-moUTP Tools for

  2026-07-09

  Explore how Firefly Luciferase mRNA with 5-moUTP modification is redefining mRNA delivery and immune cell activation. This article uniquely bridges advanced reporter assays with emerging cancer vaccine delivery insights.

• TMEM16F-Mediated Lipid Scrambling Regulates Ferroptosis Exec

  2026-07-08

  Yang et al. unveil TMEM16F as a key plasma membrane regulator that suppresses ferroptosis by orchestrating phospholipid scrambling in tumor cells. Their work clarifies how membrane lipid remodeling modulates cell death and reveals new opportunities to enhance ferroptosis-driven cancer immunotherapy.

• MARCH5 Ubiquitin Ligase Regulates Mitochondria-Derived Pre-P

  2026-07-08

  Zheng et al. uncover the essential role of ubiquitin ligase MARCH5 in the formation of PEX3-positive vesicles from mitochondria, a process crucial for de novo peroxisome biogenesis. Their findings clarify the mechanistic basis of mitochondria-peroxisome communication and provide a foundation for future studies on organelle homeostasis and protein quality control.

• BX795: Applied PDK1 Inhibitor Workflows & Assay Optimization

  2026-07-07

  BX795 is a nanomolar-potency PDK1 inhibitor enabling precision modulation of PI3K/Akt/mTOR and innate immune pathways in vitro. This article outlines practical protocols, advanced use-cases, and troubleshooting strategies for BX795, bridging the latest research on drug response metrics to maximize reproducibility and insight.

• Vernakalant Hydrochloride for Rapid Cardioversion of Recent-

  2026-07-07

  The reference study establishes Vernakalant Hydrochloride (RSD1235) as a novel, atrial-selective antiarrhythmic agent capable of rapidly converting recent-onset atrial fibrillation to sinus rhythm in emergency settings. Its unique multi-ion channel blockade profile results in high efficacy, rapid onset, and a favorable safety margin, underscoring its translational value for both clinical and research applications.

• TRPV1/TRPA1 Activation Drives TSLP Release in Nasal Epitheli

  2026-07-06

  This study demonstrates that TRPV1 and TRPA1 ion channels on nasal epithelial cells directly mediate the secretion of TSLP and related cytokines through a Ca2+/NFAT-dependent mechanism. These findings clarify the molecular basis of upper airway inflammation, providing mechanistic targets for sensory ion channel and membrane transporter research.

• Dasatinib (BMS-354825): Precision Tools for Kinase-Driven On

  2026-07-06

  Dasatinib (BMS-354825) delivers potent, reproducible Src and Bcr-Abl inhibition, empowering researchers to dissect kinase-driven malignancies and address EMT and stemness in complex cancer models. This guide details optimized workflows, protocol parameters, and troubleshooting insights to maximize experimental rigor and translational relevance.

• Sulfo-Cy3 Azide: Photostable Bioconjugation Reagent for Clic

  2026-07-05

  Sulfo-Cy3 azide is a highly water-soluble, photostable bioconjugation reagent optimized for Click Chemistry fluorescent labeling. Its sulfonated structure reduces fluorescence quenching and enables efficient labeling of alkyne-modified oligonucleotides and proteins in aqueous environments, supporting robust imaging and reproducibility in biological research.

• Tomivosertib: Advanced MNK1/2 Inhibition for Translational C

  2026-07-04

  Explore Tomivosertib, a potent MNK1 inhibitor, and its unique role in modulating translational control pathways. This article offers new insights into practical assay design, deep mechanistic context, and emerging research opportunities.

• Sanggenol L Induces Ferroptosis in NSCLC via miR-26a-1-3p/MD

  2026-07-03

  This study demonstrates that sanggenol L, a natural compound from Morus Bark, triggers ferroptosis in non-small cell lung cancer (NSCLC) cells by modulating the miR-26a-1-3p/MDM2/p53/SLC7A11 signaling axis. The findings establish a mechanistic link between miRNA regulation, p53 activation, and ferroptotic cell death, highlighting sanggenol L's potential as an anticancer agent.

• Phenothiazines Boost Macrophage Antibacterial Defense via RO

  2026-07-03

  This study reveals that phenothiazines, including perphenazine, enhance the antibacterial activity of macrophages by inducing reactive oxygen species (ROS) and autophagy. The findings highlight a host-directed therapeutic approach to tackling intracellular bacterial infections, offering new directions for research into antimicrobial resistance.

• Co-targeting BRD4 and RAC1 Disrupts Tumorigenic Pathways in

  2026-07-02

  This study demonstrates that combined inhibition of BRD4 and RAC1 using JQ1 and NSC-23766, respectively, suppresses growth, stemness, and tumorigenesis across molecular subtypes of breast cancer. Mechanistically, the approach disrupts the c-MYC–G9a–FTH1 axis and downregulates HDAC1, highlighting a promising co-targeting strategy for overcoming heterogeneity in breast cancer.

• PR-619: A Precision Tool for Functional DUB Interrogation in

  2026-07-02

  Explore how PR-619, a potent deubiquitylating enzymes inhibitor, is advancing cell-based research by enabling nuanced control of ubiquitination, autophagy, and protein aggregation. Discover unique protocol insights and translational perspectives not found in standard overviews.

• Methyl-β-cyclodextrin: Technical Guidance for Membrane Resea

  2026-07-01

  Methyl-β-cyclodextrin enables precise extraction of cholesterol and select lipids from cellular membranes, supporting controlled studies of membrane dynamics and lipid raft organization. It is strictly for laboratory research and not suitable for diagnostic or therapeutic applications.

454 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page